Skip to content
SPC Logo

Pentasa Suppositories 1g

Last Updated on eMC 25-Jul-2012 View document  | Ferring Pharmaceuticals Ltd Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 25-Jul-2012 and displayed until Current

Reasons for adding or updating:

  • Change to MA holder contact details

Date of revision of text on the SPC: 27-Jun-2011

Legal Category:POM

Black Triangle (CHM): NO

Free-text change information supplied by the pharmaceutical company:

New MAH address: Drayton Hall, Church Road, West Drayton, UB7 7PS

Updated on 01-Sep-2005 and displayed until 25-Jul-2012

Reasons for adding or updating:

  • Change to section 3 - pharmaceutical form
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 6. 5 - Nature and Contents of Container

Updated on 18-Feb-2005 and displayed until 01-Sep-2005

Reasons for adding or updating:

  • Change to section 4.8 - Undesirable Effects

Updated on 22-Sep-2004 and displayed until 18-Feb-2005

Reasons for adding or updating:

  • Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
  • Change to section 4.6 - Pregnancy and Lactation
  • Change to section 4.8 - Undesirable Effects

Updated on 04-Nov-2002 and displayed until 22-Sep-2004

Reasons for adding or updating:

  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

Updated on 13-Aug-2001 and displayed until 04-Nov-2002

Reasons for adding or updating:

  • Transferred from eMC version 1

Updated on 18-Jan-2001 and displayed until 13-Aug-2001

Reasons for adding or updating:

  • No reasons supplied

Updated on 06-Sep-1999 and displayed until 18-Jan-2001

Reasons for adding or updating:

  • No reasons supplied

Company contact details

Ferring Pharmaceuticals Ltd

Company image
Address

Drayton Hall, Church Road, West Drayton, UB7 7PS, UK

Fax

+44 (0)844 931 0051

Telephone

+44 (0)844 931 0050

Medical Information e-mail

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

mesalazine

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue